Associate / Delaware / 302-778-8422

Casey Kraning, Ph.D.

Casey Kraning, Ph.D., is a litigation Associate in Fish & Richardson’s Delaware office. Dr. Kraning was previously a summer associate with the firm in 2014 and 2015, where she focused primarily on patent litigation. She earned her Ph.D. in Biomedical Engineering and has extensive experience researching cellular and molecular medicine. Dr. Kraning works primarily with clients in the pharmaceutical industry, but also represents clients in the semiconductor and oil & gas industries. Dr. Kraning has experience in drafting discovery, working with technical experts, conducting pre-suit diligence, and working on all stages of IPRs—assisting with everything from pre-filing diligence through drafting slides for oral argument. In the pro bono sphere, Dr. Kraning has represented clients before the U.S. Citizenship and Immigration Services agency, in Delaware Family Court, and is currently assisting a public defender’s office in obtaining discovery in an 8th Amendment challenge brought by inmates on death row.  She continues to seek new opportunities to grow and strengthen her practice.


J.D., University of Pennsylvania Law School 2016
Managing Editor, Penn Intellectual Property Group Online
Awarded “Best Advocate” and “Best Appellee Brief” at the Western Regional of the AIPLA Giles Rich Moot Court

Ph.D., Cornell University 2013
Biomedical Engineering
Thesis: “The Role of Force Generation in Metastatic Cancer Progression”

M.S., Cornell University 2012
Biomedical Engineering

B.S., Butler University 2008
summa cum laude


  • Delaware 2016
  • Pennsylvania 2017
  • U.S. District Court for the District of Delaware


  • “The Herceptin® Battle Moves into the District Court,” Fish Litigation Blog (November 22, 2017)
  • “PTAB Splits on Instituting Challenges to Herceptin® Patents,” Fish Post-Grant Alerts (August 2, 2017)
  • “Pfizer Takes Aim at Herceptin® Patent at the PTAB,” Fish Post-Grant Alerts (July 12, 2017)
  • “The Last “Cabilly” Challenge Quietly Settles,” Fish Post-Grant Alerts (May 25, 2017)
  • “Rituxan® Patents Resurface at the PTA,” Fish Post-Grant Alerts (March 10, 2017)
  • “Biogen Dodges IPR Bullet on Key Tysabri® Patents,” Fish Litigation Blog (October 20, 2016)
  • “Microfabricated Collagen Tracks Facilitate Single Cell Metastatic Invasion in 3D,” Integrative Biology, 2013:5 606-16
  • “Controlling Matrix Stiffness and Topography for the Study of Tumor Cell Migration,” Cell Adhesion & Migration, 2012:6 274-9
  • “Methods in Cell Biology (Chapter: Quantifying Traction Stresses in Adherent Cells) Elsevier,” New York, 2012:110 139-78
  • “Cellular Traction Stresses Increase with Increasing Metastatic Potential,” PLoS One, 2012:7(2) e32572
  • “The Role of the Cytoskeleton in Cellular Force Generation in 2D and 3D Environments,” Physical Biology, 2011:8 015009 (selected as one of Physical Biology’s “Highlights of 2011”)
  • “Microfabrication of an Asymmetric, Multi-layered Microdevice for Controlled Release of Orally Delivered Therapeutics,” Lab on a Chip, 2008:8 1042-47
  • “Determination of Surface Coverage and Orientation of Reduced Cytochrome c on a Silica Surface with Polarized ATR Spectroscopy,” J. Phys. Chem. C, 2007:111(35) 13062-67
No Comments

Sorry, the comment form is closed at this time.